Community pharmacist-physician collaborative streptococcal pharyngitis management program.

Objectives: To describe patient outcomes associated with a community pharmacy-based, collaborative physician-pharmacist group A Streptococcus (GAS) management program.

Setting: Fifty-five chain and independent community pharmacies in Michigan, Minnesota, and Nebraska.

Practice Innovation: Pharmacists screened clinically stable adult patients who presented with signs and symptoms consistent with GAS pharyngitis from October 1, 2013, to August 1, 2014, by means of Centor criteria, and performed a physical assessment followed by a rapid antigen detection test (RADT) for eligible patients.

Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness.

Objectives: To examine the effectiveness of collaborative physician-community pharmacist programs to treat influenza-like illness (ILI) with respect to clinical outcomes and health care utilization.

Design: Prospective multicenter cohort study.

Setting: Fifty-five pharmacies in Michigan, Minnesota, and Nebraska.

Demonstration of community pharmacy and managed care organization collaboration on cardiovascular disease risk factor identification using health risk appraisal.

Objective: To integrate the resources from a local statewide managed care organization (MCO) and a supermarket pharmacy chain to conduct a comprehensive health risk appraisal (HRA). Collected data were used to assess cardiovascular risk factors and identify disease management opportunities.

Methods: An analysis to determine the prevalence of risk factors was conducted on a cross-sectional HRA survey.